Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review

GlobalData
78 Pages - GLDATA66983
$125.00

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that conducts research, develops, manufactures and commercializes generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It carries out OTC business principally through PGT Healthcare, a consumer healthcare joint venture with The Procter & Gamble Company (P&G). The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

Mar 18,2019 Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
Mar 12,2019 Ireland to lead €7 million Parkinson’s research project
Mar 01,2019 Actavis Laboratories receives Warning Letter from U.S FDA
Feb 21,2019 Insilico and Teva enter collaboration to apply predictive digital twins for biopharmaceutical production

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Teva Pharmaceutical Industries Ltd - Key Facts
Teva Pharmaceutical Industries Ltd - Key Employees
Teva Pharmaceutical Industries Ltd - Key Employee Biographies
Teva Pharmaceutical Industries Ltd - Major Products and Services
Teva Pharmaceutical Industries Ltd - History
Teva Pharmaceutical Industries Ltd - Company Statement
Teva Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Teva Pharmaceutical Industries Ltd - Business Description
Geographical Segment: Europe
Target Markets
Performance
Overview
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
Overview
R&D Overview
Teva Pharmaceutical Industries Ltd - Corporate Strategy
Teva Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Teva Pharmaceutical Industries Ltd - Strengths
Teva Pharmaceutical Industries Ltd - Weaknesses
Teva Pharmaceutical Industries Ltd - Opportunities
Teva Pharmaceutical Industries Ltd - Threats
Teva Pharmaceutical Industries Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 18, 2019: Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
Mar 12, 2019: Ireland to lead €7 million Parkinson’s research project
Mar 01, 2019: Actavis Laboratories receives Warning Letter from U.S FDA
Feb 21, 2019: Insilico and Teva enter collaboration to apply predictive digital twins for biopharmaceutical production
Feb 19, 2019: Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19, 2019: FTC enters global settlement to resolve reverse-payment charges against Teva
Feb 13, 2019: Teva reports fourth quarter and full year 2018 financial results
Feb 06, 2019: Teva expected to sell Israeli medical equipment plant for $45m
Feb 01, 2019: Teva Receives Positive Committee for Medicinal Products for Human Use CHMP Opinion for AJOVYÂ fremanezumab for the Prophylaxis of Migraine in Adults
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Teva Pharmaceutical Industries Ltd, Key Facts
Teva Pharmaceutical Industries Ltd, Key Employees
Teva Pharmaceutical Industries Ltd, Key Employee Biographies
Teva Pharmaceutical Industries Ltd, Major Products and Services
Teva Pharmaceutical Industries Ltd, History
Teva Pharmaceutical Industries Ltd, Subsidiaries
Teva Pharmaceutical Industries Ltd, Joint Venture
Teva Pharmaceutical Industries Ltd, Key Competitors
Teva Pharmaceutical Industries Ltd, Ratios based on current share price
Teva Pharmaceutical Industries Ltd, Annual Ratios
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Teva Pharmaceutical Industries Ltd, Interim Ratios
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Teva Pharmaceutical Industries Ltd, Performance Chart (2014 - 2018)
Teva Pharmaceutical Industries Ltd, Ratio Charts
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838